News

MR imaging clarifies ambiguous mammography results

Boehringer Ingelheim Office Hours in Vienna on April 19, 2018

TAmiRNA & Vivomicx announce the introduction of new technology to make preclinical drug discovery and drug development more efficient.

Tailor-made cancer treatment: new drugs, new treatment strategies

Optimising healthcare provision in Europe: MedUni Vienna to coordinate EU research programme PECUNIA

APEIRON and Evotec Achieve First Milestond in Immunooncology Alliance With Sanofi

New insights could lead to lasting improvement of stem cell therapy in horses

FDA Grants Orphan Drug Designation to Zytoprotec´s Novel Dialysis Drug

Apeiron Announces Publication of Clinical Data with Anti-GD2 Antibody Demonstrating Efficacy in Relapsed & Refractory High-Risk Neuroblastoma

How a virus becomes chronic

IMBA – The Year Review: 2017 saw Awards, Leading Publications, and New Biotech Products

Bionic reconstruction – restoration at the pychologicall interface

Hookipa Biotech Raises $60 million (€50 million) in an Oversubscribed Round C Financing

Pancreatic cancer: specific protein promotes development of pancreatitis and tumours

Innovative probe visualises tumours

Alwin Köhler receives ERC Consolidator Grant

aws Best of Biotech: Award for the best business plans in life sciences

Women and lung cancer – Long-suspected connection between female sex hormones and development of cancer identified for the first time

Clinical Studies of Advanced eMurmur Auscultation Technology Presented at AHA Scientific Sessions 2017

PIUR expands to Asian market